Experience

Syapse

• United States
• Biotechnology Research
• 100 - 200 Employee

• Senior Vice President | Strategy, Research, and Medicine

  • Jan 2022 - Present

  Senior leader guiding Syapse, a real-world data (RWD) and real-world evidence (RWE) company. Led corporate strategy and partnerships; built novel capabilities, products, and customer markets.Corporate Strategy• Strategy: Partnered with CEO and leadership to develop, communicate, and implement company strategy.• Fundraising: Supported over five funding rounds leading to over $189M in VC investment.• Board of Directors: Attended and led content development for all quarterly Board meetings for over five years.• Corporate Development/ M&A: Assessed three potential mergers and led two diligences.Go-To-Market Strategy• Life Sciences: Established new market by translating existing health system capabilities into life science offerings. Built go to market approach and developed frameworks to enable foundational pharma contracts. Market grew from <5% to >90% of revenue in 3 years. • Health Systems: Revitalized customer relationships by establishing annual Council and working groups to co-develop solutions. Forged common vision for core Syapse value proposition among health system customers with initially disparate priorities.Product Strategy• Data Strategy: Oversaw initial data improvement priorities as Syapse grew into a RWD company• Research Program: Oversaw cross-functional build of RWE capabilities and strategic research program.• Product Leadership: Co-led (dotted line) Product Management team for one year.• Product Development: Designed novel product applying Syapse strengths to unmet market need. Oversaw early productization.Strategic Alliances• Strategic Partnerships: Engaged with 50+ potential partners; established six partnerships.• RWE Alliance: Collaborated with RWE companies to create policy advocacy organization.Ken Tarkoff, former CEO of Syapse, on LinkedIn: “I need to specifically thank Alissa Winzeler, my first and best hire as I like to say, for her six years of dedicated, professional strategic leadership over the business...” Show less

• Vice President | Strategy, Research, and Medicine

  • Jun 2019 - Jan 2022

  The People team at Syapse put together a piece profiling me. You can read it here.

• Senior Director, Strategy

  • Mar 2019 - May 2019

• Director, Strategy

  • Mar 2017 - Mar 2019



McKinsey & Company

• Business Consulting and Services
• 700 & Above Employee

• Engagement Manager

  • Jul 2013 - Aug 2016

  Led teams in designing and delivering a variety of management consulting engagements, all within healthcare. Clients included leaders within provider health system, payor, and life science organizations. Problems addressed ranged from strategic to operational to organizational in nature. Strategy• Developed strategic plans for multiple regional $500M-$1B+ health systems (one improved to 20% above budget), across payor strategy, physician partnerships, service line growth, and health system partnerships.• Advised large ACO on risk management, population health, physician alignment, and care quality.• Developed a risk-based partnership between a hospital system and a large specialist group.• Performed due diligence leading to the $100M+ purchase of an IPA, health plan, and MSO.• Evaluated turn-around and exit opportunities for two hospitals within a larger regional system.Operations• Eliminated over $1M in OR costs by improving processes and avoiding unnecessary supply use variability.• Improved ED operational efficiency to 90th percentile benchmarks for ED LOS for admitted patients.• Virtually eliminated hospital-acquired pressure ulcers (a.k.a. bed sores) in ICU. Improved from annualized run-rate of 44/yr to 22/yr during three-month project; trained team that achieved 1/yr within two years.• Captured over $1M in additional revenue via improved ED point of service collections.• Reduced excess unreimbursed Medicare days by over 10%.Organizational Transformation• Transformed organizational effectiveness of the supply chain organization of a national health system, ultimately enabling capture of ~$200M in annual run-rate savings per year across the system.• Improved run-rate EBITDA margin of struggling payor by 60%+.• Re-organized provider Materials Management function to remove $2M in costs and improve effectiveness. Show less

• Associate

  • Feb 2011 - Jul 2013